This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Bloom Health Partners Past Earnings Performance
Past criteria checks 4/6
Key information
63.2%
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 141.8% |
| Return on equity | 26.2% |
| Net Margin | 10.3% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Bloom Health Partners makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 35 | 4 | 13 | 0 |
| 31 Mar 22 | 26 | 3 | 10 | 0 |
| 31 Dec 21 | 16 | 0 | 7 | 0 |
| 30 Sep 21 | 10 | -1 | 5 | 0 |
| 30 Jun 21 | 0 | -4 | 3 | 0 |
| 31 Mar 21 | 0 | -3 | 2 | 0 |
| 31 Dec 20 | 0 | -3 | 1 | 0 |
| 30 Sep 20 | 0 | 0 | 0 | 0 |
| 30 Jun 20 | 0 | 0 | 0 | 0 |
Quality Earnings: D840 has high quality earnings.
Growing Profit Margin: D840 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: D840 has become profitable over the past 5 years.
Accelerating Growth: D840 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: D840 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.8%).
Return on Equity
High ROE: D840's Return on Equity (26.2%) is considered high.